Literature DB >> 8425142

Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study.

P B Jones1, P Bebbington, A Foerster, S W Lewis, R M Murray, A Russell, P C Sham, B K Toone, S Wilkins.   

Abstract

In an investigation of the timing and precursors of social decline in schizophrenia and affective psychosis, 195 subjects from the Camberwell Collaborative Psychosis Study were currently of lower social class than were their fathers. A comparison between father's occupation and proband's best premorbid occupational level indicated underachievement confined to DSM-III schizophrenia, there being no such effect in affective psychosis. Decline in social status following onset of psychosis, analysed by comparing best premorbid occupation with current occupation, was marked in both schizophrenia and affective psychosis, indicating a non-specific effect. Schizophrenic patients who failed to achieve their fathers' social status had poorer educational qualifications than those who equalled or bettered their paternal social class, despite similar premorbid IQ (NART) scores and age at onset of psychosis. These results indicate that schizophrenia may be manifest before the onset of psychosis, and lend weight to the notion of a developmental origin to this disorder.

Entities:  

Mesh:

Year:  1993        PMID: 8425142     DOI: 10.1192/bjp.162.1.65

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  20 in total

1.  The family-school-primary care triangle and the access to mental health care among migrant and ethnic minorities.

Authors:  Marta Gonçalves; Carla Moleiro
Journal:  J Immigr Minor Health       Date:  2012-08

2.  Social disadvantage and schizophrenia. A combined neighbourhood and individual-level analysis.

Authors:  Marjan Drukker; Lydia Krabbendam; Ger Driessen; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-02       Impact factor: 4.328

Review 3.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

4.  The public mental health significance of research on socio-economic factors in schizophrenia and major depression.

Authors:  Benedetto Saraceno; Itzhak Levav; Robert Kohn
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

Review 5.  Schizophrenia.

Authors:  M Cannon; P Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

6.  Effect of social class at birth on risk and presentation of schizophrenia: case-control study.

Authors:  F Mulvany; E O'Callaghan; N Takei; M Byrne; P Fearon; C Larkin
Journal:  BMJ       Date:  2001-12-15

7.  Life events before psychotic episodes: do clinical and social variables affect the relationship?

Authors:  P Bebbington; S Wilkins; P Sham; P Jones; J van Os; R Murray; B Toone; S Lewis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-06       Impact factor: 4.328

Review 8.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study.

Authors:  Ulrich A Reininghaus; Craig Morgan; Jayne Simpson; Paola Dazzan; Kevin Morgan; Gillian A Doody; Dinesh Bhugra; Julian Leff; Peter Jones; Robin Murray; Paul Fearon; Tom K J Craig
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05-16       Impact factor: 4.328

10.  Is familiality associated with downward occupation drift in schizophrenia?

Authors:  Triptish Bhatia; Satabdi Chakraborty; Pramod Thomas; Amina Naik; Sati Mazumdar; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Psychiatry Investig       Date:  2008-09-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.